We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONN
2276
DELISTED
Conn's Inc.
CONN
| $529K | ﹤0.01% |
28,028
+8,366
| +43% | +$226K |
|
2277
Winmark
WINA
$1.27B
| $528K | ﹤0.01% |
3,323
+1,099
| +49% | +$168K |
|
2278
Rhythm Pharmaceuticals
RYTM
$7.72B
| $526K | ﹤0.01% |
19,553
+7,458
| +62% | +$206K |
|
2279
Live Oak Bancshares
LOB
$1.97B
| $523K | ﹤0.01% |
35,291
+10,890
| +45% | +$210K |
|
|
FBMS
2280
DELISTED
The First Bancshares, Inc.
FBMS
| $522K | ﹤0.01% |
17,271
+5,303
| +44% | +$185K |
|
|
COWN
2281
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $522K | ﹤0.01% |
39,093
+11,970
| +44% | +$182K |
|
2282
Kura Oncology
KURA
$824M
| $521K | ﹤0.01% |
37,118
+13,781
| +59% | +$183K |
|
2283
Johnson Outdoors
JOUT
$498M
| $520K | ﹤0.01% |
8,846
+4,297
| +94% | +$307K |
|
|
QADA
2284
DELISTED
QAD Inc.
QADA
| $518K | ﹤0.01% |
13,171
+4,377
| +50% | +$191K |
|
|
WFT
2285
DELISTED
Weatherford International plc
WFT
| $517K | ﹤0.01% |
925,164
+62,640
| +7% | +$81.8K |
|
|
BVH
2286
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $516K | ﹤0.01% |
18,011
+5,590
| +45% | +$172K |
|
|
FLXN
2287
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $516K | ﹤0.01% |
45,566
+14,713
| +48% | +$231K |
|
2288
The RMR Group
RMR
$321M
| $513K | ﹤0.01% |
9,674
+3,075
| +47% | +$217K |
|
|
LGTY
2289
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $513K | ﹤0.01% |
49,095
+12,607
| +35% | +$139K |
|
2290
DHT Holdings
DHT
$2.96B
| $508K | ﹤0.01% |
129,718
+40,038
| +45% | +$186K |
|
|
ATRS
2291
DELISTED
Antares Pharma, Inc.
ATRS
| $508K | ﹤0.01% |
186,863
+62,857
| +51% | +$207K |
|
2292
Talos Energy
TALO
$2.35B
| $507K | ﹤0.01% |
31,069
+8,765
| +39% | +$207K |
|
2293
nLIGHT
LASR
$4.26B
| $506K | ﹤0.01% |
+28,433
| New | +$538K |
|
|
AKCA
2294
DELISTED
Akcea Therapeutics Inc
AKCA
| $505K | ﹤0.01% |
16,750
+5,208
| +45% | +$146K |
|
|
JCAP
2295
DELISTED
Jernigan Capital, Inc.
JCAP
| $504K | ﹤0.01% |
25,428
+9,011
| +55% | +$183K |
|
2296
Anterix
ATEX
$1.96B
| $502K | ﹤0.01% |
13,428
+4,191
| +45% | +$164K |
|
2297
CRA International
CRAI
$1.14B
| $502K | ﹤0.01% |
11,790
+3,285
| +39% | +$148K |
|
2298
Rigel Pharmaceuticals
RIGL
$733M
| $502K | ﹤0.01% |
21,813
+7,149
| +49% | +$202K |
|
|
LCI
2299
DELISTED
Lannett Company, Inc.
LCI
| $501K | ﹤0.01% |
25,247
+3,848
| +18% | +$73.2K |
|
|
CRCM
2300
DELISTED
CARE.COM, INC.
CRCM
| $499K | ﹤0.01% |
25,842
+8,216
| +47% | +$149K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.